No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

arivis Unveils Multiuser VR For Volumetric Imaging

Editor: What To Know

  • All results can be inspected and edited in arivis VisionVR and vice versa, user knowledge can be mapped onto images in VR and used by the other arivis Platform applications (e.
  • Users of arivis VisionVR can meet in a virtual environment and work together on the same dataset.
  • 2, arivis rebrands their VR solution as arivis VisionVR and the “Vision” branding becomes the home for the entire arivis imaging product family.

arivis, a software provider for visualization, analysis, and management of big image data, announces the new VisionVR 3.2, which now enables users to simultaneously experience 3D and 4D image volumes and surfaces in an immersive environment.

Meet collaborators in VR

Users of arivis VisionVR can meet in a virtual environment and work together on the same dataset. The new collaboration functionality includes:

  • Movement, scaling and clipping of data volumes occur in real time for all participants.
  • Intranet or Internet is configurable.
  • Users see each other’s position, view direction, and hand movement.
  • Collaborators can highlight dataset features for each other
  • Virtual meetings will enable many new joint scientific discoveries and shared educational experiences!

Seamless connectivity of powerful imaging science tools

With this new version 3.2, arivis rebrands their VR solution as arivis VisionVR and the “Vision” branding becomes the home for the entire arivis imaging product family. WebView and ImageHub are now VisionHub.

These products each cover unique aspects of imaging workflows including VR-based exploration, local analysis and rendering, and server-based parallel computation. All results can be inspected and edited in arivis VisionVR and vice versa, user knowledge can be mapped onto images in VR and used by the other arivis Platform applications (e.g. AI-based image segmentation).

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy